Add Company
Join Now

ImmunoACT Revenue and Competitors

License our Company Data API

Navi Mumbai, in

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • ImmunoACT has 147 Employees.(i)
  • ImmunoACT grew their employee count by 46% last year.

ImmunoACT's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A14746%N/AN/A
#2
N/A48872%N/AN/A
#3
N/A47830%N/AN/A
#4
N/A1110%N/AN/A
#5
N/A2018%N/AN/A
#6
N/A9888%N/AN/A
#7
N/A4038%N/AN/A
#8
N/A1417%N/AN/A
#9
N/A775%N/AN/A
Add Company

What Is ImmunoACT?

Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.

keywords:N/A

N/A

Total Funding

147

Number of Employees

N/A

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.9M149-4%N/A
#2
$18.2M1589%N/A
#3
$21.4M1598%N/A
#4
N/A15923%N/A
#5
$21M168-1%N/A